top of page

Post-transition: Pharmacovigilance requirements for UK authorised products - Thursday 22 October 20


Post-transition: Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020. This webinar was part of a series of EU Exit and post-transition guidance webinars.

Comments


+447801055541

  • Facebook
  • Twitter
  • LinkedIn

©2022 by Lanatus Pharma Ltd. Proudly created with Wix.com

bottom of page